| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 671902 | N-Acetyl-1-(3-iodo-1-oxo-2-trans-propenyl)indoline-3-ethanamine | 0.0273093708703115 | 0.43596761 |
| NSC 674233 | Null | 0.0273093708703115 | 0.22206439 |
| NSC 676006 | Null | 0.0273093708703115 | 0.17693739 |
| NSC 677617 | Furan-2,3-dione, tetrahydro-4-acetoxy- 4-(1-phenyl-2-propen-1-yl)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)- | 0.0273093708703115 | 0.37502184 |
| NSC 678994 | 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- | 0.0273093708703115 | 0.32777777 |
| NSC 684909 | 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 | 0.0273093708703115 | 0.10561351 |
| NSC 698395 | Morpholine, 4,4'-(3,4-dichloro-2,4-dinitro-1,3-butadiene- 1,1-diyl)bis-, (1E,3E)- | 0.0273093708703115 | 0.48931927 |
| NSC 721513 | 2-(N,N-bis(2-bromoethyl)phosphorodiamidoxy)methyl-1-methyl-5 -methoxyindole-4,7-dione | 0.0273093708703115 | 0.099161151 |
| NSC 734872 | 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline | 0.0273093708703115 | 0.24980461 |
| NSC 742295 | (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.0273093708703115 | 0.10444787 |